Compare DRIO & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DRIO | IAE |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.1M | 80.3M |
| IPO Year | N/A | N/A |
| Metric | DRIO | IAE |
|---|---|---|
| Price | $10.76 | $8.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | 10.5K | ★ 46.3K |
| Earning Date | 03-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.21% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,732,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.64 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.29 | N/A |
| 52 Week Low | $5.94 | $5.31 |
| 52 Week High | $17.74 | $6.45 |
| Indicator | DRIO | IAE |
|---|---|---|
| Relative Strength Index (RSI) | 43.83 | 64.10 |
| Support Level | $9.94 | $8.00 |
| Resistance Level | $11.13 | $8.30 |
| Average True Range (ATR) | 0.57 | 0.09 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 32.22 | 45.95 |
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.